| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 181.97M | 223.18M | 193.25M | 184.95M | 159.43M | 181.54M |
| Gross Profit | 107.64M | 223.18M | 156.93M | 144.23M | 147.78M | 181.54M |
| EBITDA | 53.81M | 0.00 | 23.75M | 14.32M | 37.60M | 49.56M |
| Net Income | 30.31M | 35.96M | 18.07M | 11.08M | 30.14M | 39.80M |
Balance Sheet | ||||||
| Total Assets | 683.50M | 665.81M | 630.14M | 459.66M | 479.35M | 495.28M |
| Cash, Cash Equivalents and Short-Term Investments | 342.06M | 342.50M | 35.08M | 18.50M | 30.61M | 37.90M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 193.00K | 194.00K |
| Total Liabilities | 437.16M | 407.46M | 387.73M | 237.16M | 226.62M | 228.88M |
| Stockholders Equity | 246.34M | 258.35M | 242.41M | 222.50M | 252.73M | 266.40M |
Cash Flow | ||||||
| Free Cash Flow | -7.95M | 22.07M | 23.68M | 19.36M | 33.28M | 50.68M |
| Operating Cash Flow | -7.94M | 22.07M | 25.34M | 19.40M | 33.31M | 50.69M |
| Investing Cash Flow | 33.15M | 0.00 | -1.67M | -38.00K | -28.00K | -12.00K |
| Financing Cash Flow | -34.13M | -25.83M | -7.10M | -31.47M | -40.58M | -44.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £1.47B | 8.18 | 15.18% | 11.03% | 8.78% | -38.83% | |
75 Outperform | £323.92M | 8.28 | 16.39% | 4.89% | 7.77% | 35.65% | |
72 Outperform | £701.93M | -66.96 | -2.53% | 8.03% | -48.03% | -289.17% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | £2.26B | 34.86 | 5.21% | 1.22% | -7.30% | -27.69% | |
62 Neutral | £616.15M | -16.18 | -76.14% | ― | -35.05% | 74.73% | |
58 Neutral | £141.08M | 8.06 | ― | 2.90% | ― | ― |
Sabre Insurance Group plc announced that its directors and persons discharging managerial responsibilities have acquired additional shares through the Company’s Share Incentive Plan. This move, involving key figures such as the CEO, Claims Director, and Chief Actuary, signifies a commitment to aligning management interests with shareholder value, potentially enhancing investor confidence.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £1.72 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc announced that its directors and persons discharging managerial responsibilities have acquired additional shares in the company through its Share Incentive Plan. This plan allows employees to purchase shares using salary deductions and receive matching shares, which reflects the company’s commitment to employee investment and aligns management interests with those of shareholders.
The most recent analyst rating on (GB:SBRE) stock is a Hold with a £135.00 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc has announced that as of 31 October 2025, its issued and fully paid share capital consists of 246,600,000 ordinary shares, each with a nominal value of £0.001 and one voting right per share. This update is crucial for shareholders as it determines the denominator for calculating their interest in the company under the Disclosure and Transparency Rules, impacting how they report changes in their holdings.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £1.62 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc announced that David Neave, a Non-executive Director, purchased 11,625 ordinary shares in the company at an average price of 130.61 pence per share. This transaction, conducted on the London Stock Exchange, represents 0.005 percent of the company’s issued share capital, indicating a modest increase in insider ownership which may reflect confidence in the company’s future performance.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £1.62 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc has reiterated its full-year profit guidance, expecting results to align with 2024 figures, as it maintains strong pricing discipline and margin management. Despite a decrease in gross written premiums, the company has completed a £5 million share buyback and continues to generate strong capital, supporting its confidence in making an attractive capital distribution at year-end. The company is progressing well towards its Ambition 2030 goals, with expectations of market pricing increases in late 2025 or early 2026, which could bolster profitability in the coming years.
The most recent analyst rating on (GB:SBRE) stock is a Sell with a £1.16 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc announced that its directors and persons discharging managerial responsibilities have acquired additional shares in the company through its Share Incentive Plan. This move, involving key figures like the CEO, Claims Director, and Chief Actuary, reflects a commitment to align their interests with those of shareholders, potentially strengthening stakeholder confidence and enhancing the company’s market position.
The most recent analyst rating on (GB:SBRE) stock is a Sell with a £1.16 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc has executed a share buy-back program, purchasing 35,000 ordinary shares for cancellation. This transaction, conducted on the London Stock Exchange, reduces the total number of shares in issue to 246,600,000, impacting the company’s total voting rights and potentially affecting shareholder calculations under regulatory rules.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £1.78 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc has completed its on-market share buyback programme, which was initiated on 1 July 2025, with the repurchase of 3,400,000 Ordinary Shares for a total of £4,997,750. This buyback, approved by shareholders, aimed to optimize the company’s capital structure and enhance shareholder value, resulting in a total of 246,600,000 voting rights post-cancellation.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £1.78 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc has announced the purchase and cancellation of 31,635 ordinary shares as part of its share buy-back program, authorized by shareholders earlier this year. This transaction, conducted through Panmure Liberum Limited on the London Stock Exchange, impacts the total voting rights, reducing the number of shares in issue to 246,635,000, which shareholders can use to determine their interest in the company.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £1.78 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc has executed a share buy-back program, purchasing 39,937 of its own ordinary shares for cancellation. This transaction, conducted through Panmure Liberum Limited on the London Stock Exchange, is part of a strategy to manage the company’s capital structure, potentially enhancing shareholder value by reducing the number of shares in circulation, which impacts the total voting rights and may influence shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £1.78 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc has announced that as of 30 September 2025, its issued and fully paid share capital consists of 246,797,970 ordinary shares, each with a nominal value of £0.001 and one voting right per share. This update is crucial for shareholders as it determines the denominator for calculating their interest or changes in interest in the company under the Disclosure and Transparency Rules.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £1.78 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc has announced the repurchase and cancellation of 16,139 ordinary shares as part of its share buy-back program, authorized by shareholders earlier this year. This transaction, conducted through Panmure Liberum Limited, impacts the company’s total voting rights, reducing the number of shares in issue to 246,706,572, which may affect shareholder calculations under the Financial Conduct Authority’s rules.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £1.78 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.